TOEBOX KOREA.Ltd. (KOSDAQ:215480)
South Korea · Delayed Price · Currency is KRW 2,175.00
-15.00 (-0.68%)
At close: Mar 31, 2026
TOEBOX KOREA.Ltd. Revenue
TOEBOX KOREA.Ltd. had revenue of 7.50B KRW in the quarter ending September 30, 2025, a decrease of -21.16%. This brings the company's revenue in the last twelve months to 41.24B, down -10.11% year-over-year. In the year 2024, TOEBOX KOREA.Ltd. had annual revenue of 44.68B, down -8.17%.
Revenue (ttm)
41.24B
Revenue Growth
-10.11%
P/S Ratio
0.48
Revenue / Employee
1.33B
Employees
31
Market Cap
19.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.68B | -3.97B | -8.17% |
| Dec 31, 2023 | 48.65B | -2.58B | -5.04% |
| Dec 31, 2022 | 51.23B | 15.10B | 41.80% |
| Dec 31, 2021 | 36.13B | 10.81B | 42.69% |
| Dec 31, 2020 | 25.32B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WooGene B&G | 54.76B |
| PAKERS.Co.,Ltd. | 53.50B |
| Bonne | 50.94B |
| HYUNGJI INNOVATION & CREATIVE Co.,Ltd | 50.81B |
| Union Korea Pharm | 33.83B |
| DMOA Co., Ltd | 27.53B |
| BioInfra | 23.15B |
| Bistos | 19.37B |